Editing
Adrenal: Pheochromocytoma
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==== Treatment of Malignant Pheochromocytoma ==== * '''Currently, malignant pheochromocytoma can only be defined by the presence of clinical metastases'''. ** A number of pathologic criteria to differentiate benign from malignant disease have been proposed, but to date there is no criterion agreed on. *Currently therapy for metastatic pheochromocytoma is largely '''palliative'''. * '''Surgical metastasectomy of resectable disease is the standard of care''' ** Little evidence exists to demonstrate that it prolongs patient survival or is more effective for symptomatic relief than medical treatment with Ξ±/Ξ²-blockade and Ξ±-methyl-p-tyrosine * Chemotherapy is primarily used in patients in whom MIBG therapy has failed or in those whose tumors do not demonstrate MIBG uptake on initial MIBG imaging studies.
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information